{"product_id":"retatrutide-40-mg-multi-dose-injection-pen","title":"Retatrutide 40 mg Multi-Dose Injection Pen","description":"\u003cdiv class=\"flex max-w-full flex-col gap-4 grow\"\u003e\n\u003cdiv dir=\"auto\" class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+\u0026amp;]:mt-1\" tabindex=\"0\"\u003e\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden\"\u003e\n\u003cdiv class=\"markdown prose dark:prose-invert wrap-break-word w-full dark markdown-new-styling\"\u003e\n\u003ch2 class=\"PDq2pG_selectionAnchorContainer\"\u003eRetatrutide 40 mg Multi-Dose Pen\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide 40 mg Multi-Dose Pen\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA pre-filled multi-dose pen containing \u003cstrong\u003e40 mg of retatrutide\u003c\/strong\u003e. Retatrutide is an \u003cstrong\u003einvestigational triple agonist\u003c\/strong\u003e that activates the \u003cstrong\u003eGIP, GLP-1 and glucagon receptor pathways\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIt is currently being investigated in Phase 3 clinical research across obesity, type 2 diabetes and several metabolic and cardiovascular-related conditions. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Retatrutide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTotal strength:\u003c\/strong\u003e 40 mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 8 mg \/ 0.6 mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e Pre-filled multi-dose pen\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePresentation:\u003c\/strong\u003e Purple and white packaging\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhat is Retatrutide?\u003c\/h3\u003e\n\u003cp\u003eRetatrutide is a single peptide molecule designed to activate three hormonal receptor pathways:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eGIP — glucose-dependent insulinotropic polypeptide\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eGLP-1 — glucagon-like peptide-1\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eGlucagon\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis triple-pathway activity makes retatrutide a significant area of current metabolic research. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eResearch Areas\u003c\/h3\u003e\n\u003cp\u003eCurrent research into retatrutide includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody-weight regulation\u003c\/strong\u003e — clinical trials have investigated its effects on body weight in adults with obesity or overweight.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppetite regulation\u003c\/strong\u003e — researchers are studying the interaction between GIP, GLP-1 and glucagon pathways and appetite.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose metabolism\u003c\/strong\u003e — research includes glucose and HbA1c-related outcomes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnergy metabolism\u003c\/strong\u003e — the combination of three hormonal pathways is being investigated for its effects on energy balance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiometabolic research\u003c\/strong\u003e — studies are examining cardiovascular and metabolic markers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLipid metabolism\u003c\/strong\u003e — research includes changes in cholesterol and triglyceride-related markers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLiver and metabolic disease research\u003c\/strong\u003e — retatrutide is being investigated in conditions including metabolic dysfunction-associated steatotic liver disease (MASLD). \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eType 2 diabetes research\u003c\/strong\u003e — Phase 3 studies have investigated retatrutide in adults with obesity\/overweight and type 2 diabetes. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eInvestigational Status\u003c\/h3\u003e\n\u003cp\u003eRetatrutide is \u003cstrong\u003enot currently approved by the FDA\u003c\/strong\u003e and remains an investigational medicine. Lilly states that it is currently being studied in Phase 3 clinical trials and that it is not available for public use outside those trials. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eStorage \u0026amp; Handling\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eStore refrigerated at \u003cstrong\u003e2–8°C\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eDo not freeze.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eProtect from direct sunlight and excessive heat.\u003c\/li\u003e\n\u003cli\u003eKeep out of reach of children and pets.\u003c\/li\u003e\n\u003cli\u003eDo not use if the product or packaging appears damaged or compromised.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFor Research Purposes Only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HilverPeptides","offers":[{"title":"Default Title","offer_id":57195064885626,"sku":null,"price":299.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/5380\/2106\/files\/ChatGPTImageAug22_2026_04_50_15PM.png?v=1787414968","url":"https:\/\/hilverpeptides.co.uk\/products\/retatrutide-40-mg-multi-dose-injection-pen","provider":"HilverPeptides","version":"1.0","type":"link"}